The gut microbial environment (bacteria and metabolites) may have a role in obesity. Urinary enterolignan concentrations can provide a marker of interindividual differences in microbial environments. Analysis was conducted on 6806 individuals from 2003 to 2008 National Health and Nutrition Examination Survey data, and weight status, waist circumference groups and high-vs low-enterolignan concentration was evaluated using multinomial logistic regression, adjusted for personal and dietary factors. High-enterolignan concentrations were defined as the 90th percentile value and greater. High-enterodiol concentration was associated with 18% and 42% lower likelihood of being overweight and obese, respectively, and 48% lower likelihood of having high-risk waist circumference among adults. High-enterolactone concentration was associated with 24% and 64% lower likelihood of being overweight and obese, respectively. Age and sex were not modifiers of these associations. These results from a large human study population provide additional evidence supporting the microbiome-obesity relationship.
INTRODUCTION
There are notable interindividual differences in the gut microbiome, 1 which could translate to host health-impacting differences in functional capacity across individuals, and obesity is a particular concern. Differences in the gut microbiome have been observed in obese individuals compared with non-obese individuals. 1 Lignans are found in plant foods, and in high concentrations in grains, legumes and seeds, 2 and are metabolized to enterolignans (enterolactone and enterodiol) in the gut by microorganisms. 3 High urinary enterolignan concentrations provide a marker of a microbial environment capable of biotransforming lignan precursors. Urinary metabolic phenotypes, such as highenterolignan-producing phenotype, provide an efficient means of evaluating microbiome-disease relationships in large, human studies. The objective of this analysis was to evaluate weight status in relation to urinary concentrations of enterolignans, in order to address the hypothesis that an enterolignan-producing phenotype is associated with obesity.
SUBJECTS AND METHODS
Cross-sectional data from the National Health and Nutrition Examination Survey was used. 4 Weight status was classified by World Health Organization standards: normal weight (body mass index (BMI)o25), overweight (BMI 25-29.9) and obese (BMIX30). Dietary data from the in-person 24-recall was used to create food categories. 5 Enterolignans and creatinine were measured from a spot urine sample using highperformance liquid chromatography and Jaffe rate reaction, respectively. Individuals without complete dietary information (n ¼ 335), anthropometric data (n ¼ 53), or who reported prior-month use of antibacterial prescription medications (generic drug codes with first level of 1 and second level from 9 to 406; n ¼ 352) were excluded. In a subgroup of adults with BMI 25-34 (n ¼ 2316), waist circumference groups of low risk and high risk (101.6 cm for men and 88.9 cm for women) were evaluated. This analysis used publicly available de-identified data, and was considered exempt from George Mason University IRB review.
Three data cycles (2003) (2004) (2005) (2006) (2007) (2008) were used to increase sample size. Analyses accounted for the multistage, stratified, cluster-sampling design of National Nutrition and Health Examination Survey. 6 Environmental 2-year weights provided for the phytoestrogen data were utilized. Low-vs high-enterolignan concentrations were defined at the 90th percentile to increase sensitivity for identifying high excreters. Multinomial logistic regression models were fit with weight status or waist circumference categories as the dependent variable. Analyses were adjusted for age, sex, race, energy intake and frequency intakes of grain, vegetable, fruit, meat and dairy. Analyses were conducted using Stata/MP 11.1 (StataCorp, College Station, TX, USA).
RESULTS
Enterodiol ranged from below detectable limit (BDL) to 119,340 nmol/l (90th percentile value ¼ 62.5 nmol/l). Enterolactone ranged from BDL to 408,940 nmol/l, (90th percentile value ¼ 385.5 nmol/l). Creatinine-adjusted values ranged from BDL to 64.9 for enterodiol, with 0.67 as the 90th percentile value, and from BDL to 471.9 for enterolactone, with 5.65 as the 90th percentile value. Individuals with high-enterodiol and enterolactone concentrations were older, more likely to female, and more likely to be non-Hispanic White (Table 1) . There were differences in the frequency intake of some food groups across individuals with high-enterolignan concentrations.
High-enterodiol concentration was associated with 18% and 42% lower likelihood of being overweight and obese, respectively (Table 2) .
High-enterolactone concentration was associated with 24% and 64% lower likelihood of being overweight and obese, respectively. There was a suggestion that relationships were stronger in children and in females, but directionality was the same in all of the subgroups and no statistically significant interactions were observed. In the waist circumference subgroup analysis, individuals were significantly 38% less likely to be the high-risk waist circumference group for high-enterodiol group. 
DISCUSSION
In this analysis, obese individuals were less likely to have highenterolignan concentrations. There are several proposed mechanisms by which bacteria in the gut and obesity are related, including an increase in the energy extraction from non-digestible food components, alterations in gut permeability and gut hormone release in response to gut microbial metabolites. 1 The goal of this analysis was not to identify particular mechanisms, but to identify if further work in this area, possibly using cellular or animal models, is warranted.
Lignans are metabolized through several different types of microbial biotransformation reactions in the gut. 3, 7 High concentrations of enterolignans provide a nonspecific marker of a microbial environment because they do not identify particular bacteria associated with enterolignan production. Several strains of bacteria can perform metabolic steps of lignans to enterolignans. Clavel et al. 8 identified 11 species capable of reactions in the process of metabolizing the lignan secoisolariciresinol diglucoside to enterodiol and enterolactone. These results suggest that there is not one single bacterium capable of lignan metabolism, but rather several similar bacteria capable of different biotransformation steps. In this study, highenterodiol concentration was more strongly associated than highenterolactone concentration. Enterolactone is one step further in the lignan metabolism pathway than enterodiol, 3, 7 suggesting that the earlier steps may be more involved with an obeseassociated microbial environment. An overall microbial environment might be an important risk factor in a microbiome-disease relationship, and these results provide a foundation for looking more the enterolignan-producing phenotype and other metabolic phenotypes.
A limitation of this study is that it is cross-sectional in design, and it is not possible to determine whether gut microbial profiles influenced weight or vice versa. However, some evidence from other polyphenol-metabolizing phenotypes suggests that such phenotypes may be established early in life and remain stable in adults. 9, 10 These results provide a foundation for future work to evaluate temporal sequence. A possible limitation is exercise and other medications that may be associated with BMI were not included in the analysis due to low precision and low frequency, respectively. These variables are not major confounders due to their lack of strong associations with the microbiome; thus, exclusion would likely not influence conclusions of this study.
Results from this analysis in a large human study population provide a novel observation that obese individuals were less likely to have high-enterolignan concentrations. Adjustment for other possible confounders did not alter these results, suggesting that the association between weight and having a gut microbial environment capable of producing enterolignans is independent of age, gender, race and dietary factors considered in this analysis. These results support further work in this area, possibly using cellular or animal models, to identify biological mechanisms. 
